An award-winning pathologist who devoted his life to melanoma research became the first person to receive a novel ...

The FDA has approved an application to initiate a pilot study with Alpha DaRT for patients with recurrent glioblastoma, a ...

Alpha Tau Medical Ltd. (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ®, announced today that the FDA has approved an Investigational Device Exemption ...

In high-grade gliomas (17 glioblastoma). 1 Department of Medical Oncology, Bellaria-Maggiore Hospital, Azienda USL of Bologna, Bologna, Italy 2 Department of Neurosurgery, Bellaria-Maggiore ...

The FDA has approved an investigational device exemption (IDE) application for the start of a pilot study evaluating the Alpha diffusing alpha-emitters radiation therapy (DaRT) technology in patients ...

Spanios is pleased to announce strategic partnership with GlioGuard aimed at propelling discovery and validation of ...

The current standard of care for GBM involves surgical resection, radiation, and chemotherapy, which have been shown in studies to result in significant toxicity. However, large-scale clinical trials ...

Considered the most aggressive and common form of brain cancer, approximately 14,000 people suffer from glioblastoma in the ...

An Instagram reel claims that Nicotine cures glioblastoma tumors in less than 72 hours. The claim by the user is ...